|
Marshall, M V; Carey, K D; Von Hoff, D D et al. (1995) Hepsulfam distribution in blood, plasma and cerebrospinal fluid of baboons. Invest New Drugs 13:33-6
|
|
Marshall, M V; Marshall, M H; Degen, D R et al. (1993) In vitro cytotoxicity of hepsulfam against human tumor cell lines and primary human tumor colony forming units. Stem Cells 11:62-9
|
|
Havlin, K A; Kuhn, J G; Craig, J B et al. (1991) Phase I clinical and pharmacokinetic trial of flavone acetic acid. J Natl Cancer Inst 83:124-8
|
|
Von Hoff, D D; Turner, J (1991) Response rates, duration of response, and dose response effects in phase I studies of antineoplastics. Invest New Drugs 9:115-22
|
|
Phillips, J L; Schwartz, R; Von Hoff, D D (1989) In vitro distribution of diacetyl didemnin B in human blood cells and plasma. Cancer Invest 7:123-8
|
|
Friess, G G; Brown, T D; Wrenn, R C (1989) Cardiovascular rhythm effects of gamma recombinant DNA interferon. Invest New Drugs 7:275-80
|
|
Scheithauer, W; Moyer, M P; Clark, G M et al. (1988) Application of a new preclinical drug screening system for cancer of the large bowel. Cancer Chemother Pharmacol 21:31-4
|
|
Merkel, D E; Griffin, N L; Kagan-Hallet, K et al. (1986) Central nervous system toxicity with fludarabine. Cancer Treat Rep 70:1449-50
|
|
Scheithauer, W; Clark, G M; Salmon, S E et al. (1986) Model for estimation of clinically achievable plasma concentrations for investigational anticancer drugs in man. Cancer Treat Rep 70:1379-82
|
